National Stock Number
6505-01-593-6465
National Stock Number (NSN) 6505-01-593-6465, or NIIN 015936465, (influenza virus vaccine) was assigned April 13, 2011 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There is only one manufacturer part number associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, there are no suppliers that are deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of Nov 16, 2011. There has been one contract issued for this part number, with 3 awards given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPM2DP11D0006, SPM2DP11D0006, SPM2DP11D0006. The total value of the awarded contracts has been US$ 1,798,454.80.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Jan 25, 2018, this NSN's acquisition method was noted as: Suitable for Competitive Acquisition. (Potential sources shall include dealers/distributors.) The Government has unlimited rights to the technical data, and the data package is complete. Valid AMCs: 1 and 2.
This NSN is assigned to Item Name Code (INC) 22781. [A VACCINE INDICATED FOR ACTIVE IMMUNIZATION FOR THE PREVENTION OF INFLUENZA DISEASE CAUSED BY INFLUENZA A SUBTYPE VIRUSES AND TYPE B VIRUSES CONTAINED IN THE VACCINE.]. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505015936465 does not contain precious metals.
This NSN is associated to Schedule B 3002200000: vaccines for human medicine. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325414: biological product (except diagnostic) manufacturing.
This information was last updated on May 01, 2024.